{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:08:56Z","timestamp":1772147336151,"version":"3.50.1"},"reference-count":92,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1111\/jcpt.12357","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T06:13:46Z","timestamp":1453875226000},"page":"7-18","source":"Crossref","is-referenced-by-count":60,"title":["Quetiapine safety in older adults: a systematic literature review"],"prefix":"10.1155","volume":"41","author":[{"given":"N.","family":"El-Saifi","sequence":"first","affiliation":[{"name":"Menzies Health Institute Queensland; Griffith University; QLD Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Moyle","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland; Griffith University; QLD Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jones","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland; Griffith University; QLD Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tuffaha","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland; Griffith University; QLD Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"10.1111\/jcpt.12357-BIB0001|jcpt12357-cit-0001","unstructured":"Australian Institute of Health and Welfare Mental health services-in brief 2014 http:\/\/www.aihw.gov.au\/publication-detail\/?id=60129549463"},{"key":"10.1111\/jcpt.12357-BIB0002|jcpt12357-cit-0002","unstructured":"American Psychological Association Growing Mental and Behavioral Health Concerns Facing Older Americans http:\/\/www.apa.org\/about\/gr\/issues\/aging\/growing-concerns.aspx"},{"key":"10.1111\/jcpt.12357-BIB0003|jcpt12357-cit-0003","unstructured":"Australian Bureau of Statistics National Survey of Mental Health and Wellbeing: Summary of Results, 2007 http:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/4326.0"},{"key":"10.1111\/jcpt.12357-BIB0004|jcpt12357-cit-0004","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1037\/a0025393","article-title":"Aging and mental health in the decade ahead: what psychologists need to know","volume":"67","author":"Karel","year":"2012","journal-title":"Am Psychol"},{"key":"10.1111\/jcpt.12357-BIB0005|jcpt12357-cit-0005","unstructured":"Australian Bureau of Statistics Mental Health http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/Lookup\/1301.0Chapter11082009%E2%80%9310"},{"key":"10.1111\/jcpt.12357-BIB0006|jcpt12357-cit-0006","unstructured":"Bloom DE Cafiero ET Jan\u00e9-Llopis E et\u00a0al The Global Economic Burden of Noncommunicable Diseases"},{"key":"10.1111\/jcpt.12357-BIB0007|jcpt12357-cit-0007","unstructured":"Medicines and Healthcare Products Regulatory Agency Antipsychotics learning module London 2015 http:\/\/webarchive.nationalarchives.gov.uk\/20150122075153\/http:\/\/mhra.gov.uk\/conferenceslearningcentre\/learningcentre\/medicineslearningmodules\/antipsychoticslearningmodule\/con155606?usesecondary=&showpage=3"},{"key":"10.1111\/jcpt.12357-BIB0008|jcpt12357-cit-0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995-2008","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12357-BIB0009|jcpt12357-cit-0009","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1111\/jcpt.12357-BIB0010|jcpt12357-cit-0010","unstructured":"Food and Drug Administration (FDA) Highlights of prescribing information"},{"key":"10.1111\/jcpt.12357-BIB0011|jcpt12357-cit-0011","unstructured":"Therapeutic Goods Administration (TGA) Product and consumer information, quetiapine: Australian Government Department of Health https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/PICMI?OpenForm&t=&q=quetiapine"},{"key":"10.1111\/jcpt.12357-BIB0012|jcpt12357-cit-0012","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1741-6612.2008.00308.x","article-title":"Antipsychotic use in the elderly: what doctors say they do, and what they do","volume":"27","author":"Tiller","year":"2008","journal-title":"Australas J Ageing"},{"key":"10.1111\/jcpt.12357-BIB0013|jcpt12357-cit-0013","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/ps.2009.60.9.1175","article-title":"Off-label use of antipsychotic medications in the department of Veterans Affairs health care system","volume":"60","author":"Leslie","year":"2009","journal-title":"Psychiatr Serv"},{"key":"10.1111\/jcpt.12357-BIB0014|jcpt12357-cit-0014","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/ps.2010.61.2.130","article-title":"Off-label use of second-generation antipsychotic agents among elderly nursing home residents","volume":"61","author":"Kamble","year":"2010","journal-title":"Psychiatr Serv"},{"key":"10.1111\/jcpt.12357-BIB0015|jcpt12357-cit-0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/11632030-000000000-00000","article-title":"Off-label use of atypical antipsychotics","volume":"26","author":"McKean","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1111\/jcpt.12357-BIB0016|jcpt12357-cit-0016","unstructured":"Department of Health and Ageing Pharmaceutical benefits scheme expenditure and prescriptions twelve months to 30 June 2011"},{"key":"10.1111\/jcpt.12357-BIB0017|jcpt12357-cit-0017","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1399-5618.2008.00614.x","article-title":"Quetiapine for the treatment of bipolar mania in\u00a0older adults","volume":"10","author":"Sajatovic","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1111\/jcpt.12357-BIB0018|jcpt12357-cit-0018","unstructured":"Information for Healthcare Professionals http:\/\/www.fda.gov\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ucm124830.htm"},{"key":"10.1111\/jcpt.12357-BIB0019|jcpt12357-cit-0019","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/0897190007304982","article-title":"Antipsychotic medication use in the elderly patient","volume":"20","author":"Malone","year":"2007","journal-title":"J Pharm Pract"},{"key":"10.1111\/jcpt.12357-BIB0020|jcpt12357-cit-0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1192\/apt.11.4.286","article-title":"Treatment of psychosis in elderly people","volume":"11","author":"Karim","year":"2005","journal-title":"Adv Psychiatr Treat"},{"key":"10.1111\/jcpt.12357-BIB0021|jcpt12357-cit-0021","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0149-2918(00)80085-5","article-title":"Long-Term use of quetiapine in elderly patients with psychotic disorders","volume":"22","author":"Tariot","year":"2000","journal-title":"Clin Ther"},{"key":"10.1111\/jcpt.12357-BIB0022|jcpt12357-cit-0022","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2125.2003.01875.x","article-title":"Adverse drug reactions in elderly patients","volume":"57","author":"Routledge","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12357-BIB0023|jcpt12357-cit-0023","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.320.7237.741","article-title":"Incidence and types of preventable adverse events in elderly patients: population based review of medical records","volume":"320","author":"Thomas","year":"2000","journal-title":"BMJ"},{"key":"10.1111\/jcpt.12357-BIB0024|jcpt12357-cit-0024","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1310\/hpj4811-931","article-title":"Adverse drug reactions: a retrospective review of hospitalized patients at a state psychiatric hospital","volume":"48","author":"Iuppa","year":"2013","journal-title":"Hosp Pharm"},{"key":"10.1111\/jcpt.12357-BIB0025|jcpt12357-cit-0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation vs. first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12357-BIB0026|jcpt12357-cit-0026","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YIC.0b013e3283430a0e","article-title":"Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials","volume":"26","author":"Zhornitsky","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0027|jcpt12357-cit-0027","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1542\/peds.2011-2158","article-title":"Antipsychotics for children and young adults: a\u00a0comparative effectiveness review","volume":"129","author":"Seida","year":"2012","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12357-BIB0028|jcpt12357-cit-0028","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1017\/S1461145712001277","article-title":"Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0029|jcpt12357-cit-0029","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12357-BIB0030|jcpt12357-cit-0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12357-BIB0031|jcpt12357-cit-0031","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00023210-200923030-00007","article-title":"Quetiapine extended release: in schizophrenia","volume":"23","author":"Baldwin","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1111\/jcpt.12357-BIB0032|jcpt12357-cit-0032","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial","volume":"330","author":"Ballard","year":"2005","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12357-BIB0033|jcpt12357-cit-0033","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00228-010-0828-z","article-title":"Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara","volume":"66","author":"Chiabrando","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12357-BIB0034|jcpt12357-cit-0034","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/gps.2720","article-title":"Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and\/or agitation: a randomised, double-blind, parallel-group study","volume":"27","author":"De Deyn","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0035|jcpt12357-cit-0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jagp.2013.01.010","article-title":"Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder","volume":"21","author":"Katila","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0036|jcpt12357-cit-0036","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.pnpbp.2006.04.001","article-title":"Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report","volume":"30","author":"Kobayashi","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0037|jcpt12357-cit-0037","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1017\/S1092852900021386","article-title":"Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports","volume":"12","author":"Kohen","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1111\/jcpt.12357-BIB0038|jcpt12357-cit-0038","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gps.3867","article-title":"Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder","volume":"28","author":"Mezhebovsky","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0039|jcpt12357-cit-0039","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/gps.1892","article-title":"Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study","volume":"23","author":"Paleacu","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0040|jcpt12357-cit-0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.jcp.0000186870.75042.25","article-title":"periodic restless legs syndrome associated with quetiapine use: a case report","volume":"25","author":"Pinninti","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0041|jcpt12357-cit-0041","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.21116","article-title":"Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3\u00a0months' duration","volume":"22","author":"Rabey","year":"2007","journal-title":"Mov Disord"},{"key":"10.1111\/jcpt.12357-BIB0042|jcpt12357-cit-0042","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.eurpsy.2007.03.001","article-title":"Quetiapine vs. risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function","volume":"22","author":"Rainer","year":"2007","journal-title":"Eur Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0043|jcpt12357-cit-0043","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1017\/S1461145712001599","article-title":"Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature","volume":"16","author":"Rittmannsberger","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0044|jcpt12357-cit-0044","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1440-1819.2007.01729.x","article-title":"Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study","volume":"61","author":"Rocca","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1111\/jcpt.12357-BIB0045|jcpt12357-cit-0045","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/JCP.0b013e3181f1d0f2","article-title":"A pilot, 8-week, placebo lead-in trial of quetiapine extended release for depression in midlife women: impact on mood and menopause-related symptoms","volume":"30","author":"Soares","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0046|jcpt12357-cit-0046","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.JGP.0000196628.12010.35","article-title":"Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial","volume":"14","author":"Tariot","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0047|jcpt12357-cit-0047","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1471-244X-13-240","article-title":"Efficacy and safety of haloperidol vs. atypical antipsychotic medications in the treatment of\u00a0delirium","volume":"13","author":"Yoon","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0048|jcpt12357-cit-0048","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/156720507779939805","article-title":"Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study","volume":"4","author":"Zhong","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1111\/jcpt.12357-BIB0049|jcpt12357-cit-0049","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40266-012-0013-4","article-title":"Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study","volume":"29","author":"Chatterjee","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1111\/jcpt.12357-BIB0050|jcpt12357-cit-0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S1041610205002280","article-title":"Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events vs. other antipsychotics","volume":"17","author":"Finkel","year":"2005","journal-title":"Int Psychogeriatr"},{"key":"10.1111\/jcpt.12357-BIB0051|jcpt12357-cit-0051","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38330.470486.8F","article-title":"Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study","volume":"330","author":"Gill","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/jcpt.12357-BIB0052|jcpt12357-cit-0052","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1532-5415.2011.03853.x","article-title":"Comparative safety of antipsychotic medications in nursing home residents","volume":"60","author":"Huybrechts","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/jcpt.12357-BIB0053|jcpt12357-cit-0053","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0269881105056524","article-title":"Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia","volume":"19","author":"Layton","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0054|jcpt12357-cit-0054","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0269881113482530","article-title":"Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study","volume":"27","author":"Shin","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0055|jcpt12357-cit-0055","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/1533317506294775","article-title":"Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia","volume":"21","author":"Onor","year":"2007","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1111\/jcpt.12357-BIB0056|jcpt12357-cit-0056","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.WNF.0000228176.98582.93","article-title":"Long-term follow-up (24\u00a0months) of quetiapine treatment in drug-induced Parkinson disease psychosis","volume":"29","author":"Klein","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/jcpt.12357-BIB0057|jcpt12357-cit-0057","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjopharm.2011.10.006","article-title":"Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study","volume":"10","author":"Chatterjee","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1111\/jcpt.12357-BIB0058|jcpt12357-cit-0058","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/jgs.12216","article-title":"Fracture risk in nursing home\u00a0residents initiating antipsychotic medications","volume":"61","author":"Rigler","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/jcpt.12357-BIB0059|jcpt12357-cit-0059","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0269881105056669","article-title":"The efficacy and safety of quetiapine for treatment of geriatric psychosis","volume":"19","author":"Yang","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0060|jcpt12357-cit-0060","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/SMJ.0b013e3180f607cf","article-title":"A challenging case of syndrome of inappropriate secretion of antidiuretic hormone in an elderly patient secondary to quetiapine","volume":"100","author":"Atalay","year":"2007","journal-title":"South Med J"},{"key":"10.1111\/jcpt.12357-BIB0061|jcpt12357-cit-0061","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/JCP.0b013e3181dac52f","article-title":"Prazosin vs. quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety","volume":"30","author":"Byers","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0062|jcpt12357-cit-0062","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10401230701844612","article-title":"Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004)","volume":"20","author":"DuMouchel","year":"2008","journal-title":"Ann Clin Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0063|jcpt12357-cit-0063","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/YIC.0b013e32832d6c18","article-title":"Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population","volume":"24","author":"Duncan","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1111\/jcpt.12357-BIB0064|jcpt12357-cit-0064","first-page":"w13772","article-title":"Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland","volume":"143","author":"Greil","year":"2013","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/jcpt.12357-BIB0065|jcpt12357-cit-0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4088\/JCP.12m08001","article-title":"Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization","volume":"74","author":"Jin","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0066|jcpt12357-cit-0066","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.farma.2009.10.010","article-title":"Utilisation of atypical antipsychotic drugs in institutionalised elderly persons and prevalence of metabolic alterations","volume":"34","author":"Mart\u00ednez Romero","year":"2010","journal-title":"Farm Hosp"},{"key":"10.1111\/jcpt.12357-BIB0067|jcpt12357-cit-0067","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2005-871245","article-title":"Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report","volume":"38","author":"Takahashi","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1111\/jcpt.12357-BIB0068|jcpt12357-cit-0068","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1176\/appi.ajp.2008.08081218","article-title":"Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study","volume":"166","author":"Zheng","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0069|jcpt12357-cit-0069","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jamda.2008.08.005","article-title":"Atypical antipsychotics and the risk of diabetes in an elderly population in long-term care: a retrospective nursing home chart review study","volume":"10","author":"Albert","year":"2009","journal-title":"J Am Med Dir Assoc"},{"key":"10.1111\/jcpt.12357-BIB0070|jcpt12357-cit-0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/aje\/kwj289","article-title":"Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia","volume":"164","author":"Lambert","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1111\/jcpt.12357-BIB0071|jcpt12357-cit-0071","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.pnpbp.2006.02.007","article-title":"New-onset type-2 diabetes associated with atypical antipsychotic medications","volume":"30","author":"Lambert","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0072|jcpt12357-cit-0072","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.psychres.2007.06.015","article-title":"Quetiapine for elderly non-responsive schizophrenia patients","volume":"157","author":"Mazeh","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1111\/jcpt.12357-BIB0073|jcpt12357-cit-0073","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/15622970802176495","article-title":"Quetiapine-associated dysphagia","volume":"10","author":"Kohen","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0074|jcpt12357-cit-0074","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/gps.3999","article-title":"Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: a prospective observational study","volume":"29","author":"Hatta","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0075|jcpt12357-cit-0075","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1532-5415.2010.02873.x","article-title":"Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?","volume":"58","author":"Rossom","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/jcpt.12357-BIB0076|jcpt12357-cit-0076","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0891988712436687","article-title":"Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder","volume":"25","author":"Bhalerao","year":"2012","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1111\/jcpt.12357-BIB0077|jcpt12357-cit-0077","doi-asserted-by":"crossref","first-page":"e977","DOI":"10.1136\/bmj.e977","article-title":"Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study","volume":"344","author":"Huybrechts","year":"2012","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12357-BIB0078|jcpt12357-cit-0078","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2011.11030347","article-title":"Risk of mortality among individual antipsychotics in patients with dementia","volume":"169","author":"Kales","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0079|jcpt12357-cit-0079","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4088\/JCP.08m04597yel","article-title":"All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study","volume":"70","author":"Liperoti","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0080|jcpt12357-cit-0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/JGP.0b013e3182051bd6","article-title":"Antipsychotics and mortality in Parkinsonism","volume":"20","author":"Marras","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0081|jcpt12357-cit-0081","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/JGP.0b013e31813547ca","article-title":"Antipsychotic medication dispensing and risk of death in veterans and war widows 65\u00a0years and older","volume":"15","author":"Hollis","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0082|jcpt12357-cit-0082","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","article-title":"Antipsychotic drug use and mortality in older adults with dementia","volume":"146","author":"Gill","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12357-BIB0083|jcpt12357-cit-0083","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1192\/bjp.bp.112.122499","article-title":"Comparative mortality risks of antipsychotic medications in community-dwelling older adults","volume":"205","author":"Gerhard","year":"2014","journal-title":"Br J Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0084|jcpt12357-cit-0084","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/pds.1334","article-title":"All-cause mortality associated with atypical and typical antipsychotics in demented outpatients","volume":"16","author":"Trifir\u00f2","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12357-BIB0085|jcpt12357-cit-0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjopharm.2012.11.001","article-title":"Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex","volume":"10","author":"Marras","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1111\/jcpt.12357-BIB0086|jcpt12357-cit-0086","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1345\/aph.1G495","article-title":"Acute respiratory failure with a single dose of quetiapine fumarate","volume":"40","author":"Jabeen","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12357-BIB0087|jcpt12357-cit-0087","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1532-5415.2009.01911.x","article-title":"Quetiapine-induced dystonia and agitation in Parkinson disease with dementia: a case report","volume":"57","author":"Leey","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/jcpt.12357-BIB0088|jcpt12357-cit-0088","first-page":"598","article-title":"A 73-year-old woman with Parkinson's disease, psychotic symptoms","volume":"36","author":"Mahgoub","year":"2006","journal-title":"Psychiatr Ann"},{"key":"10.1111\/jcpt.12357-BIB0089|jcpt12357-cit-0089","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1176\/appi.ajp.2010.10091292","article-title":"Fatal hepatotoxicity in an elderly patient receiving low-dose quetiapine","volume":"168","author":"Naharci","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1111\/jcpt.12357-BIB0090|jcpt12357-cit-0090","first-page":"209","article-title":"Priapism associated with quetiapine in an elderly patient","volume":"34","author":"Andr\u00e9s","year":"2006","journal-title":"Actas Esp Psiquiatr"},{"key":"10.1111\/jcpt.12357-BIB0091|jcpt12357-cit-0091","first-page":"80","article-title":"Sleepwalking in four patients treated with quetiapine","volume":"25","author":"Raja","year":"2013","journal-title":"Psychiatr Danub"},{"key":"10.1111\/jcpt.12357-BIB0092|jcpt12357-cit-0092","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.pnpbp.2009.07.024","article-title":"Drug-induced Pisa syndrome under quetiapine","volume":"33","author":"Walder","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12357","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12357","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12357\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:06:12Z","timestamp":1671818772000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12357","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}